Correlation Between EPIRUS Biopharmaceutica and Pharvaris
Can any of the company-specific risk be diversified away by investing in both EPIRUS Biopharmaceutica and Pharvaris at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining EPIRUS Biopharmaceutica and Pharvaris into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between EPIRUS Biopharmaceuticals and Pharvaris BV, you can compare the effects of market volatilities on EPIRUS Biopharmaceutica and Pharvaris and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in EPIRUS Biopharmaceutica with a short position of Pharvaris. Check out your portfolio center. Please also check ongoing floating volatility patterns of EPIRUS Biopharmaceutica and Pharvaris.
Diversification Opportunities for EPIRUS Biopharmaceutica and Pharvaris
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between EPIRUS and Pharvaris is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding EPIRUS Biopharmaceuticals and Pharvaris BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharvaris BV and EPIRUS Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on EPIRUS Biopharmaceuticals are associated (or correlated) with Pharvaris. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharvaris BV has no effect on the direction of EPIRUS Biopharmaceutica i.e., EPIRUS Biopharmaceutica and Pharvaris go up and down completely randomly.
Pair Corralation between EPIRUS Biopharmaceutica and Pharvaris
If you would invest 0.01 in EPIRUS Biopharmaceuticals on August 31, 2024 and sell it today you would earn a total of 0.00 from holding EPIRUS Biopharmaceuticals or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 4.35% |
| Values | Daily Returns |
EPIRUS Biopharmaceuticals vs. Pharvaris BV
Performance |
| Timeline |
| EPIRUS Biopharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Pharvaris BV |
EPIRUS Biopharmaceutica and Pharvaris Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with EPIRUS Biopharmaceutica and Pharvaris
The main advantage of trading using opposite EPIRUS Biopharmaceutica and Pharvaris positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if EPIRUS Biopharmaceutica position performs unexpectedly, Pharvaris can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharvaris will offset losses from the drop in Pharvaris' long position.| EPIRUS Biopharmaceutica vs. NovAccess Global | EPIRUS Biopharmaceutica vs. Vg Life Sciences | EPIRUS Biopharmaceutica vs. Genenta Science SpA | EPIRUS Biopharmaceutica vs. Molecular Partners AG |
| Pharvaris vs. Cue Biopharma | Pharvaris vs. Eliem Therapeutics | Pharvaris vs. Inhibrx | Pharvaris vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Transaction History View history of all your transactions and understand their impact on performance |